CRIS Current Research Information System

CONTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.838
AS - Asia 3.558
EU - Europa 2.467
AF - Africa 239
SA - Sud America 162
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.790
VN - Vietnam 1.194
SG - Singapore 993
CN - Cina 699
GB - Regno Unito 606
IT - Italia 424
SE - Svezia 361
DE - Germania 294
HK - Hong Kong 228
FR - Francia 149
IN - India 137
RU - Federazione Russa 133
BR - Brasile 115
IE - Irlanda 103
NL - Olanda 87
CI - Costa d'Avorio 71
BD - Bangladesh 62
TG - Togo 62
ZA - Sudafrica 60
UA - Ucraina 56
EE - Estonia 51
JP - Giappone 39
CH - Svizzera 33
JO - Giordania 33
BG - Bulgaria 32
PH - Filippine 31
CA - Canada 30
BE - Belgio 29
TH - Thailandia 28
AT - Austria 26
FI - Finlandia 25
NG - Nigeria 24
PL - Polonia 18
AR - Argentina 17
KR - Corea 16
TR - Turchia 15
IQ - Iraq 14
ID - Indonesia 13
TW - Taiwan 12
IR - Iran 11
MX - Messico 11
PK - Pakistan 11
EC - Ecuador 10
SC - Seychelles 8
ES - Italia 6
AU - Australia 5
CO - Colombia 5
LT - Lituania 5
PT - Portogallo 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
VE - Venezuela 4
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
HR - Croazia 3
KE - Kenya 3
LB - Libano 3
MK - Macedonia 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
IL - Israele 2
LV - Lettonia 2
MY - Malesia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
GL - Groenlandia 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 11.272
Salva come PNG Salva come JPEG
Città #
Singapore 729
Fairfield 537
Southend 536
Ashburn 495
Chandler 380
San Jose 267
Ho Chi Minh City 266
Houston 232
Woodbridge 218
Hanoi 212
Seattle 212
Hong Kong 204
Wilmington 197
Dallas 183
Ann Arbor 179
Dong Ket 154
Santa Clara 154
Cambridge 153
Princeton 118
Bologna 108
Boardman 107
Beijing 106
Dublin 102
Abidjan 71
Los Angeles 68
Nanjing 67
Lomé 62
New York 58
Westminster 53
Da Nang 50
Lauterbourg 49
Padova 43
Haiphong 41
Milan 37
Amman 33
San Diego 32
São Paulo 31
Tokyo 31
Berlin 30
Jinan 30
Sofia 30
Brussels 29
Council Bluffs 29
Bern 28
Saint Petersburg 28
Turin 28
Florence 27
Frankfurt am Main 27
Bremen 26
Buffalo 25
Jacksonville 24
Redondo Beach 24
Abeokuta 23
Guangzhou 22
Tianjin 22
Chicago 20
London 20
Shenyang 20
Nanchang 18
Helsinki 17
Hải Dương 17
Munich 17
Redmond 17
Vienna 17
Biên Hòa 16
Changsha 16
Dearborn 16
Medford 15
Phoenix 15
Bến Tre 14
Quận Ba 14
Rome 14
Falls Church 13
Bangkok 12
Bắc Ninh 12
The Dalles 12
Amsterdam 11
Hebei 11
Shanghai 11
Warsaw 11
Wuhan 11
Des Moines 10
Thái Nguyên 10
Toronto 10
Yubileyny 10
Brooklyn 9
Can Tho 9
Haikou 9
Hangzhou 9
Johannesburg 9
Montreal 9
Orem 9
Atlanta 8
Bình Phước 8
Moscow 8
Stockholm 8
Xi'an 8
Zhengzhou 8
Fuzhou 7
Lanzhou 7
Totale 7.579
Salva come PNG Salva come JPEG
Nome #
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 296
Monofocal hepatocellular carcinoma: How much does size matter? 295
Point quantification elastography in the evaluation of liver elasticity in healthy volunteers: a reliability study based on operator expertise 285
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 265
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 244
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 235
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 221
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 217
Alcohol and viral hepatitis: a mini-review. 213
The changing scenario of hepatocellular carcinoma in Italy: an update 209
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 209
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 208
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 207
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 207
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 206
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 205
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 204
Vitamins in the treatment of chronic viral hepatitis. 201
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 199
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 199
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 197
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 196
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 194
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 189
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study 189
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 188
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 187
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 184
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 184
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 184
Chronic hepatitis B: Are we close to a cure? 183
Treating hepatitis C in the elderly: the future is near? 181
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 180
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 177
A New Two-Dimensional Shear Wave Elastography for Noninvasive Assessment of Liver Fibrosis in Healthy Subjects and in Patients with Chronic Liver Disease - Eine neue zweidimensionale Shear-Wave-Elastografie zur nicht-invasiven Beurteilung der Leberfibrose bei Gesunden und bei Patienten mit chronischer Lebererkrankung 176
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 174
SP714SHEAR WAVE ELASTOGRAPHY IN KIDNEY TRANSPLANTATION: NONINVASIVE ALTERNATIVE TO ALLOGRAFT BIOPSY? 167
Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis 165
Liver Stiffness improvement in subjects with advanced chronic hepatitis C treated with direct antiviral agents. 163
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 156
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 155
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 152
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 151
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 150
Bile salt export pump deficiency disease: Two novel, late onset, ABCB11 mutations identified by next generation sequencing 150
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 147
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 147
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 135
Liver AL amyloidosis as a possible cause of high liver stiffness values. 134
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 133
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals 131
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 128
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 124
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 123
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 123
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 123
IMPULSIONAL, POINT AND BIDIMENSIONAL SHEAR WAVE ELASTOMETRY FOR PORTAL HYPERTENSION: SAME STIFFNESS THRESHOLDS? 121
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 119
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 118
Liver AL amyloidosis as a possible cause of high liver stiffness values. 116
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection. 111
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver. 110
null 107
null 96
null 92
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 82
Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs 48
Totale 11.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.387
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 0 0 0 0 0 0 275
2021/20221.329 119 40 67 82 102 56 19 79 35 128 398 204
2022/20231.458 133 213 70 229 96 127 51 75 242 33 113 76
2023/2024363 29 58 24 31 38 85 11 33 21 18 7 8
2024/20251.383 62 219 113 127 209 71 99 42 18 115 42 266
2025/20263.795 301 165 377 210 388 177 560 185 860 272 141 159
Totale 11.465